Systemic Lupus Erythematosus (SLE) Clinical Trials

Find Systemic Lupus Erythematosus (SLE) Clinical Trials Near You

A Prospective Cohort Study on Long-Term Outcomes in Patients With Systemic Lupus Erythematosus at Peking University People's Hospital

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study aims to prospectively follow patients diagnosed with Systemic Lupus Erythematosus (SLE) at Peking University People's Hospital, assessing long-term outcomes such as disease activity, organ involvement, survival, and quality of life. Findings will support individualized patient management and contribute to understanding disease progression in the Chinese population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• All patients must meet at least one of the following classification criteria for Systemic Lupus Erythematosus (SLE):

⁃ The 1997 American College of Rheumatology (ACR) Revised Classification Criteria; The 2012 Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria; The 2019 EULAR/ACR Classification Criteria for SLE. All patients must be over the age of 18 and competent to provide written consent.

Locations
Other Locations
China
Department of Rheumatology and Immunology, Peking University People's Hospital
RECRUITING
Beijing
Contact Information
Primary
Haihong Yao, MD
yaohaihong@pku.edu.cn
010-88326666
Time Frame
Start Date: 2020-05-21
Estimated Completion Date: 2032-05-20
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: Peking University People's Hospital

This content was sourced from clinicaltrials.gov